Biodesix (BDSX) Interest Expenses (2019 - 2026)

Biodesix has reported Interest Expenses for 8 years, with the latest figure at $2.0 million in Q1 2026.

• For the quarter ending Q1 2026, Interest Expenses rose 17.33% year-over-year to $2.0 million; the trailing twelve-month figure through Mar 2026 stood at $8.0 million (up 8.03% YoY), and the FY2025 full-year result was $7.7 million, down 6.56% from the prior year.
• Interest Expenses for Q1 2026 stood at $2.0 million, down from $2.1 million in the prior quarter.
• The five-year high for Interest Expenses was $3.0 million in Q3 2022, with the low at $1.1 million in Q1 2022.
• Historically, Interest Expenses has averaged $2.1 million across 5 years, with a median of $2.1 million in 2025.
• Annual changes were most pronounced in 2023 — Interest Expenses soared 110.29% — and 2025, when it slumped 33.37%.
• Biodesix's Interest Expenses stood at $2.6 million in 2022, then retreated by 8.67% to $2.3 million in 2023, then declined by 24.77% to $1.8 million in 2024, then rose by 17.52% to $2.1 million in 2025, then decreased by 3.98% to $2.0 million in 2026.
• The last three Interest Expenses figures came in at $2.0 million (Q1 2026), $2.1 million (Q4 2025), and $2.1 million (Q3 2025), per Business Quant data.